SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-14-150906
Filing Date
2014-04-21
Accepted
2014-04-21 16:55:33
Documents
5
Group Members
PS MANAGEMENT GP, LLCWILLIAM A. ACKMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d711603dsc13d.htm SC 13D 95089
2 EX-99.1 d711603dex991.htm EX-99.1 6506
3 EX-99.2 d711603dex992.htm EX-99.2 24587
4 EX-99.3 d711603dex993.htm EX-99.3 34782
5 EX-99.4 d711603dex994.htm EX-99.4 53012
  Complete submission text file 0001193125-14-150906.txt   215512
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-40724 | Film No.: 14774263
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D